🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Germ Cell Tumor of Testis

A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors NCT07453082n/a1 site📍 Candiolo Fondazione del Piemonte per l'Oncologia Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity NCT07463508NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: blood sampling, Tissue sampling Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors NCT06276491Phase 127 sites📍 Duarte📍 Palo Alto📍 San Francisco Xencor, Inc. · Tests: XmAb541 Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer NCT06133543NA1 site📍 Düsseldorf Heinrich-Heine University, Duesseldorf · Tests: Robot-assisted ICG-guided sentinel lymph node biopsy Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Navigation Intervention for Adolescent and Young Adult Cancer Survivors NCT07406087NA1 site📍 Pasadena Kaiser Permanente · Tests: Adapted patient navigation program targeting adolescent and young adult cancer survivors A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Study of GV20-0251 in Advanced or Refractory Solid Tumors NCT07106827Phase 11 site📍 Chengdu West China Hospital · Tests: GV20-0251 THERApy De-escalation for TESTicular Cancer NCT06309745n/a1 site📍 London Queen Mary University of London · Tests: retroperitoneal lymph node dissection, Carboplatin AUC10 Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer NCT07614620NA1 site📍 Bordeaux Institut Bergonié · Tests: HYPNOSIS Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients NCT05588700NA12 sites📍 Angers📍 Besançon📍 Bordeaux Centre Leon Berard · Tests: Physical activity recommendations, Connected activity tracker, Physical Activity (PA) Intervention Follow-up After Surgery for Testicular Cancer NCT05670938n/a1 site📍 Rotterdam Erasmus Medical Center Germ Cell Tumor and Testicular Tumor DNA Registry NCT02099734n/a8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Questionnaires, sample of blood or saliva Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites📍 Gilbert📍 Tucson📍 Seattle University of Arizona · Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy NCT06866964Phase 23 sites📍 Charlotte📍 Winston-Salem📍 Milwaukee Wake Forest University Health Sciences · Tests: Low-dose ASA MicroRNA as Markers in Testicular Cancer NCT04914026n/a6 sites📍 Bergen📍 Haugesund📍 Oslo Haukeland University Hospital · Tests: Biomarker analysis International PPB/DICER1 Registry NCT03382158n/a1 site📍 Minneapolis Children's Hospitals and Clinics of Minnesota DESTINY-PANTUMOUR04 NCT07124000n/a18 sites📍 Birmingham📍 Bullhead City📍 Casa Grande AstraZeneca · Tests: Trastuzumab deruxtecan Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer NCT07498959NA1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: primary RPLND for low-stage metasatatic seminoma, 3 courses of chemotherapy; Blemocin, Etoposide and Platinum (BEP) At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors NCT07218913Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Audiometric Test, Cisplatin, Computed Tomography, Magnetic Resonance Imaging, Sodium Thiosulfate Anhydrous Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy NCT06828185NA1 site📍 Loma Linda Loma Linda University · Tests: Radical inguinal orchiectomy, Radical external oblique fascia sparing orchiectomy Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline NCT07847190Phase 21 site📍 Moscow Blokhin's Russian Cancer Research Center · Tests: Paclitaxel, Bleomycin, Etoposide, Cisplatin, G-CSF (Filgrastim) Sentinel Node Identification Using Gamma and Near-Infrared Imaging in TesticulAr MaLignancies NCT07777887n/a1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: Standard treatment: orchiectomy followed by drug therapy and, if necessary, retroperitoneal lymphadenectomy, sentinel l… A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases NCT06932458Phase 21 site📍 London Western University, Canada · Tests: Retroperitoneal Lymph Node Dissection MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial NCT06060873n/a7 sites📍 Birmingham📍 Loma Linda📍 Los Angeles University of Southern California · Tests: Clinical Stage I Disease, Clinical Stage I with relapse, CSII Disease
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy